Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

Bibliographic Details
Main Authors:	Hassan Alwafi, Ian C. K. Wong, Abdallah Y. Naser, Amitava Banerjee, Pajaree Mongkhon, Cate Whittlesea, Alaa Alsharif, Li Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Medicine
Subjects:	oral anticoagulants hypoglycemia sulfonylureas diabetes mellitus United Kingdom drug-drug interactions
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1337712/full

Similar Items

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study
by: Hassan Alwafi, et al.
Published: (2022-08-01)

Hypoglycemia After Ingestion of “Street Valium” Containing Glyburide, Alcohol, and Cocaine
by: Amanda L. McKenna, MD, et al.
Published: (2024-07-01)

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
by: Aleksey Vadimovich Zilov, et al.
Published: (2010-06-01)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
by: Alla Vsevolodovna Rudakova
Published: (2011-09-01)

OCTREOTIDE FOR TREATMENT RECURRENT HYPOGLYCEMIA INDUCED BY SULFONYLUREA: A CASE REPORT AND LITERATURE REVIEW
by: Yuddy Imowanto, et al.
Published: (2024-09-01)

Doxycyline-induced hypoglycemia in a nondiabetic older woman
by: Sara Sabeti, BS, et al.
Published: (2024-06-01)

The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies
by: Mansour Bahardoust, et al.
Published: (2023-05-01)

Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population‐Based Cohort Study
by: Teddy Tai Loy Lee, et al.
Published: (2022-09-01)

Case report - sulfonylurea poisoning mimicking vertebrobasilar acute ischemic stroke
by: Kamila Kędra, et al.
Published: (2023-04-01)

Analysis of Burden and Outcomes of Oral Hypoglycaemic Agent Induced Adverse Drug Effects at a Tertiary Care Centre
by: Kavita S Joshi, et al.
Published: (2022-05-01)

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
by: Gregory Y H Lip, et al.
Published: (2024-08-01)

The association between dementia and the risk of hypoglycaemia events among patients with diabetes mellitus: a propensity-score matched cohort analysis
by: Alaa A. Alsharif, et al.
Published: (2023-07-01)

Photodegradation of Flucetosulfuron, a Sulfonylurea-Based Herbicide in the Aqueous Media Is Influenced by Ultraviolet Irradiation
by: Arnab Goon, et al.
Published: (2021-11-01)

Synthesis of sulfonylurea derivatives and their α-glucosidase inhibitory activity
by: Thi Thoi Bui, et al.
Published: (2022-03-01)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
by: Kunavisarut T, et al.
Published: (2019-05-01)

Diagnosis of artificial hypoglycemia due to oral hypoglycemic drugs by high-performance liquid chromatography with tandem mass spectrometric detection
by: M. Y. Yukina, et al.
Published: (2024-03-01)

Hypoglycemia and hyperglycemia: potential risks of polypragmasia in type 2 diabetes in hospital settings
by: Yu. A. Sorokina, et al.
Published: (2018-03-01)

Genetically proxied antidiabetic drugs targets and stroke risk
by: Yahui Zhu, et al.
Published: (2023-09-01)

The relationship between components of hypoglycemia worries and avoiding hypoglycemia behavior in type 2 diabetes mellitus with hypoglycemia: a network analysis
by: Chao Wu, et al.
Published: (2023-03-01)

Complementary Strategy Enhancing Broad-Specificity for Multiplexed Immunoassay of Adulterant Sulfonylureas in Functional Food
by: Zhaodong Li, et al.
Published: (2022-08-01)

Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
by: Carlos K H Wong, et al.
Published: (2019-12-01)

Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study
by: Mohammad Rezazadeh, et al.
Published: (2024-10-01)

Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan
by: Michiko Yamazaki, et al.
Published: (2024-11-01)

Novel Sulfonylurea Derivatives as Potential Antimicrobial Agents: Chemical Synthesis, Biological Evaluation, and Computational Study
by: Fan-Fei Meng, et al.
Published: (2023-02-01)

Design, synthesis and in vitro evaluation of novel sulfonylurea and sulfonylthiourea as ectonucleotidases inhibitors
by: Abdullah Yahya Abdullah Alzahrani, et al.
Published: (2024-01-01)

Assessing the environmental risks of sulfonylurea pollutants: Insights into the risk priority and structure-toxicity relationships
by: Zhi-Cong He, et al.
Published: (2025-03-01)

Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
by: Olga D. Ostroumova, et al.
Published: (2020-04-01)

Management of Hypoglycemia in Neonatal Period
by: Özlem Sangün, et al.
Published: (2013-04-01)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013-06-01)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
by: Pamela Bowman, et al.
Published: (2023-12-01)

Therapeutic drug monitoring : newer drugs and biomarkers /
by: Dasgupta, Amitava, 1958-
Published: (2012)

Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study
by: Khaled Naja, et al.
Published: (2024-09-01)

A view at postbariatric hypoglycemia by endocrinologist
by: E. I. Kim, et al.
Published: (2022-02-01)

Increased Frequency of Severe Hypoglycemia with the Modified-Release Gliclazide Compared to Glimepiride in Diabetic Older Adults; Propensity Score-Adjusted Analysis
by: Fouad Algendy A, et al.
Published: (2022-05-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

Hypoglycemia in the hospital
by: Mansur Shomali, Md
Published: (2011-07-01)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
by: Almigbal TH
Published: (2021-09-01)

Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
by: Bodo Haas, et al.
Published: (2024-07-01)

Editorial: Allergy in the Asia Pacific
by: Mongkhon Sompornrattanaphan, et al.
Published: (2025-02-01)

Recurrent hypoglycemia and a slowly rising hemidiaphragm: A case report
by: Vincent Simpson, et al.
Published: (2021-07-01)